Hem#265 Rar [ TOP 2025 ]
Nuclear receptors, such as the Retinoic Acid Receptor (RAR), are critical in gene regulation but often difficult to monitor in real-time within living cells. This paper explores the development of a GR-RAR chimeric protein, which fuses the nuclear/cytoplasmic translocation properties of the Glucocorticoid Receptor (GR) with the ligand responsiveness of RAR. This chimeric receptor provides a robust, in vivo, real-time translocation assay to detect physiological concentrations of RAR ligands, providing a powerful tool for ligand identification and subcellular trafficking analysis. 1. Introduction
Development and Application of a Glucocorticoid/Retinoic Acid Receptor (GR-RAR) Chimera for In Vivo Translocation Assays Hem#265 rar
This paper highlights a novel method that combines the ligand-binding domain (LBD) of RAR with the trafficking machinery of the GR, creating a chimeric receptor that moves from the cytoplasm to the nucleus upon ligand binding. 2. Methodology: Design of the GR-RAR Chimera Nuclear receptors, such as the Retinoic Acid Receptor
Do you need me to expand on the (such as specific cell lines used)? Methodology: Design of the GR-RAR Chimera Do you
Upon the introduction of the normal RAR ligand, all-trans-retinoic acid, the chimeric receptor undergoes nuclear translocation. 3. Results: Translocation Tracking
The chimeric receptor provides a dramatic and easily monitored visual indicator of RAR ligand presence in the cellular environment.
